R104L (p.Arg104Leu) variant of MFN2 (Mitofusin-2)
R104L (p.Arg104Leu) in MFN2 (Mitofusin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Charcot-Marie-Tooth disease type 2; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.87 / 1. The record also includes published literature and structural context.
R104L (p.Arg104Leu) variant details
- p.Arg104Leu
- rs863224068
- ClinGen CA320635
- ClinVar RCV000532246
- ClinVar RCV000711275
- Conflicting interpretations
- Charcot-Marie-Tooth disease type 2; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.874
- AlphaMissense 0.93
- MetaLR 0.90
- MetaSVM 0.88
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.60
- ClinVar: Conflicting classifications of pathogenicity (Charcot-Marie-Tooth disease type 2; not provided)
- EBI: Pathogenic (in CMT2A2A and HMSN6A)
- UniProt: Pathogenic (in CMT2A2A and HMSN6A)
- Structural context available
- Cited in: Charcot-Marie-Tooth Hereditary Neuropathy Overview. (PMID 20301532)
- Cited in: MFN2 Hereditary Motor and Sensory Neuropathy. (PMID 20301684)